Humana, CVS Health In the Running to Acquire Cano Health - Reports
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Humana, CVS Health In the Running to Acquire Cano Health - Reports
September 23, 2022 12:18 PM EDT
Citi analyst Jason Cassorla reiterated a Buy rating and $7.00 price target on Cano Health (NYSE: CANO).
The analyst comments "Another Takeout Headline Not Surprising: Multiple headlines over the past ~six months have suggested CANO could potentially be acquired. To this end, CANO traded at ~1.0x our 2023E revenue at an unaffected price of $6.31 (September 21st close), which compares to its SPAC merger multiple at ~3x forward revenue, and other recent deals in the space including AMZNs... More
September 22, 2022 3:28 PM EDT
CVS Health (NYSE: CVS) Said to Consider Potential Bid for Cano Health (NYSE: CANO) - Bloomberg
...
More
September 22, 2022 5:56 AM EDT
CVS Health (NYSE: CVS) declared a quarterly dividend of $0.55 per share, or $2.2 annualized.
The dividend will be payable on November 1, 2022, to stockholders of record on October 21, 2022, with an ex-dividend date of October 20, 2022.
The annual yield on the dividend is 2.2... More
September 20, 2022 3:31 PM EDT
By Dietrich Knauth
(Reuters) -CVS Health Corp and Walmart Inc have agreed to pay $147.5 million to settle West Virginia's claims over their alleged roles in the state's opioid crisis, state attorney general Patrick Morrisey said Tuesday.
CVS agreed to pay $82.5 million and Walmart agreed to pay approximately $65 million, according to the state.
West Virginia had been prepared to proceed to trial on Sept. 26 against the two companies, as well as Walgreens Boots Alliance.
The state had accused the pharmacy chains of fueling the deadly opioid epidemic through their allegedly lax oversight of prescription pills sold in the... More
